Systemic Sclerosis Classification: A Rose by Any Other Name Would Smell As Sweet?-Reference-Cited by-同舟云学术

Systemic Sclerosis Classification: A Rose by Any Other Name Would Smell As Sweet?

Published:2015-01 Issue:1 Volume:42 Page:11-13
ISSN:0315-162X
Container-title:The Journal of Rheumatology
language:en
Short-container-title:J Rheumatol

Author:

POPE JANET E.

Publisher

The Journal of Rheumatology

Subject

Immunology,Immunology and Allergy,Rheumatology

Reference10 articles.

1. Preliminary criteria for the classification of systemic sclerosis (scleroderma)

2. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative

3. 2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative

4. Performance of the 2013 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Systemic Sclerosis (SSc) in Large, Well-defined Cohorts of SSc and Mixed Connective Tissue Disease

5. Evaluation of the new ACR/EULAR criteria for the classification of systemic sclerosis in the Canadian Scleroderma Research Group Cohort;Alhajeri;J Rheumatol,2014

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regarding: Clinical presentation, course, and prognosis of patients with mixed connective tissue disease;Journal of Internal Medicine;2024-01-04

2. Classification and Disease Subsets in Clinical Practice;Scleroderma;2024

3. A Narrative Review of Pathogenetic and Histopathologic Aspects, Epidemiology, Classification Systems, and Disease Outcome Measures in Systemic Sclerosis;Clinical Reviews in Allergy & Immunology;2022-03-07

4. Novel classifications for systemic sclerosis: challenging historical subsets to unlock new doors;Current Opinion in Rheumatology;2020-09-15

5. The nosology of systemic sclerosis: how lessons from the past offer new challenges in reframing an idiopathic rheumatological disorder;The Lancet Rheumatology;2019-12